|
US3666767A
(en)
|
1970-01-28 |
1972-05-30 |
Warner Lambert Co |
2-amino-1-(2-imidazolin-2-yl)-2-imidazolines
|
|
US4863919A
(en)
|
1988-02-01 |
1989-09-05 |
A. H. Robins Company, Incorporated |
Method of enhancing memory or correcting memory deficiency with arylamido(and arylthiomido)-azabicycloalkanes
|
|
JP3087763B2
(ja)
|
1990-11-30 |
2000-09-11 |
三井化学株式会社 |
新規な複素環式化合物およびそれを含有する医薬組成物
|
|
TW300219B
(cg-RX-API-DMAC10.html)
|
1991-09-14 |
1997-03-11 |
Hoechst Ag |
|
|
JP2553020B2
(ja)
|
1991-11-07 |
1996-11-13 |
吉富製薬株式会社 |
キヌクリジン化合物およびその医薬用途
|
|
FR2730995B1
(fr)
|
1995-02-23 |
1997-04-04 |
Cird Galderma |
Composes bi-aromatiques derives d'amide, compositions pharmaceutiques et cosmetiques les contenant et utilisations
|
|
CZ220498A3
(cs)
|
1996-01-17 |
1998-11-11 |
Novo Nordisk A/S |
Deriváty 1,2,4-thiadiazinu a 1,4-thiazinu, příprava a použití
|
|
US6225310B1
(en)
|
1996-01-17 |
2001-05-01 |
Novo Nordisk A/S |
Fused 1,2,4-thiadiazine derivatives, their preparation and use
|
|
US7214686B2
(en)
|
1997-06-30 |
2007-05-08 |
Targacept, Inc. |
Pharmaceutical compositions and methods for effecting dopamine release
|
|
US6624173B1
(en)
|
1997-06-30 |
2003-09-23 |
Targacept, Inc. |
Pharmaceutical compositions for treating and/or preventing CNS disorders
|
|
US6462036B1
(en)
|
1998-11-06 |
2002-10-08 |
Basf Aktiengesellschaft |
Tricyclic pyrazole derivatives
|
|
US6953855B2
(en)
*
|
1998-12-11 |
2005-10-11 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
|
US6727070B2
(en)
|
2000-02-14 |
2004-04-27 |
The Board Of Regents, The University Of Texas System |
Protein/solubility folding assessed by structural complementation
|
|
AU2001241056A1
(en)
|
2000-03-09 |
2001-09-17 |
Mitsubishi Pharma Corporation |
Spiro compounds, process for preparing the same and use thereof as drugs
|
|
WO2002000222A1
(en)
|
2000-06-26 |
2002-01-03 |
Novo Nordisk A/S |
Use of potassium channel agonists for the treatment of cancer
|
|
PE20021019A1
(es)
*
|
2001-04-19 |
2002-11-13 |
Upjohn Co |
Grupos azabiciclicos sustituidos
|
|
AR036041A1
(es)
*
|
2001-06-12 |
2004-08-04 |
Upjohn Co |
Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
|
|
CZ2004408A3
(cs)
|
2001-10-02 |
2005-03-16 |
Pharmacia & Upjohn Company |
Azabicyklicky substituované kondenzované heteroarylsloučeniny
|
|
EP1453792B1
(en)
|
2001-11-19 |
2007-04-18 |
Elan Pharmaceuticals, Inc. |
Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
|
|
US20030109519A1
(en)
|
2001-11-30 |
2003-06-12 |
Jeppe Sturis |
Use of selective potassium channel openers
|
|
US20030125323A1
(en)
|
2001-11-30 |
2003-07-03 |
Jeppe Sturis |
Use of selective potassium channel openers
|
|
DE10164139A1
(de)
|
2001-12-27 |
2003-07-10 |
Bayer Ag |
2-Heteroarylcarbonsäureamide
|
|
US20040192594A1
(en)
|
2002-01-28 |
2004-09-30 |
Paul Reid |
Modified neurotoxins as therapeutic agents for the treatment of diseases and methods of making
|
|
JP2003267977A
(ja)
|
2002-03-14 |
2003-09-25 |
Yamanouchi Pharmaceut Co Ltd |
キヌクリジン誘導体
|
|
MXPA04009541A
(es)
|
2002-03-29 |
2005-01-25 |
Chiron Corp |
Benzazoles sustituidos y uso de los mismos como inhibidores de cinasa raf.
|
|
US8299108B2
(en)
|
2002-03-29 |
2012-10-30 |
Novartis Ag |
Substituted benzazoles and methods of their use as inhibitors of raf kinase
|
|
US20030235583A1
(en)
|
2002-06-14 |
2003-12-25 |
Jeppe Sturis |
Combined use of a modulator of CD3 and a beta cell resting compound
|
|
MXPA05000754A
(es)
|
2002-07-17 |
2005-04-19 |
Warner Lambert Co |
Combinacion de un inhibidor carboxilico alosterico de la metaloproteinasa de matriz-13 con celecoxib o valdecoxib.
|
|
DE10234424A1
(de)
|
2002-07-29 |
2004-02-12 |
Bayer Ag |
Benzothiophen-, Benzofuran- und Indolharnstoffe
|
|
WO2004013137A1
(en)
|
2002-08-01 |
2004-02-12 |
Pharmacia & Upjohn Company Llc |
1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity
|
|
WO2004014377A1
(en)
|
2002-08-13 |
2004-02-19 |
Warner-Lambert Company Llc |
4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors
|
|
AU2003253186A1
(en)
|
2002-08-13 |
2004-02-25 |
Warner-Lambert Company Llc |
Fused tetrahydropyridine derivatives as matrix metalloproteinase inhibitors
|
|
MXPA05001702A
(es)
|
2002-08-14 |
2005-04-19 |
Neurosearch As |
Derivados de quinuclidina novedosos y su uso.
|
|
PL374946A1
(en)
|
2002-09-05 |
2005-11-14 |
Aventis Pharma S.A. |
Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
|
|
BR0315056A
(pt)
|
2002-11-01 |
2005-08-16 |
Pharmacia & Upjohn Co Llc |
Compostos tendo tanto atividade agonista nicotìnica de alfa7 quanto atividade antagonista de 5ht3 para o tratamento de doenças do sistema nervoso central
|
|
AU2003269413A1
(en)
*
|
2002-11-01 |
2004-05-25 |
Pharmacia & Upjohn Company Llc |
Nicotinic acetylcholine agonists in the treatment of glaucoma and retinal neuropathy
|
|
AU2003279492A1
(en)
*
|
2002-12-11 |
2004-06-30 |
Pharmacia & Upjohn Company Llc |
Treatment of diseases with combinations of alpha 7 nicotinic acetylcholine receptor agonists and other compounds
|
|
RU2339624C2
(ru)
|
2002-12-12 |
2008-11-27 |
Авентис Фарма С.А. |
Производные аминоиндазолов и их применение в качестве ингибиторов киназ
|
|
WO2005004794A2
(en)
|
2003-06-09 |
2005-01-20 |
Alnylam Pharmaceuticals Inc. |
Method of treating neurodegenerative disease
|
|
WO2005016923A1
(en)
|
2003-08-13 |
2005-02-24 |
Neurosearch A/S |
Novel quinuclidine derivatives and their pharmaceutical use
|
|
EP1682126B1
(en)
|
2003-10-16 |
2009-07-01 |
Novartis Vaccines and Diagnostics, Inc. |
Substituted benzazoles and use thereof as inhibitors of raf kinase
|
|
US7241773B2
(en)
|
2003-12-22 |
2007-07-10 |
Abbott Laboratories |
3-quinuclidinyl heteroatom bridged biaryl derivatives
|
|
US20050239853A1
(en)
|
2004-02-04 |
2005-10-27 |
Tjeerd Barf |
New compounds
|
|
ATE437880T1
(de)
|
2004-02-04 |
2009-08-15 |
Neurosearch As |
Dimere azacyclische verbindungen und deren verwendung
|
|
WO2005092890A2
(en)
|
2004-03-25 |
2005-10-06 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
|
|
DE602005024677D1
(de)
|
2004-04-22 |
2010-12-23 |
Memory Pharm Corp |
Indole, 1h-indazole, 1,2-benzisoxazole, 1,2-benzoisothiazole, deren herstellung und verwendungen
|
|
US7514450B2
(en)
|
2004-05-19 |
2009-04-07 |
Neurosearch A/S |
Azabicyclic aryl derivatives
|
|
US8686011B2
(en)
|
2004-05-24 |
2014-04-01 |
Amgen Inc. |
Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
|
|
AU2005247929B2
(en)
|
2004-05-24 |
2010-03-11 |
Amgen Inc. |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
GB0415746D0
(en)
*
|
2004-07-14 |
2004-08-18 |
Novartis Ag |
Organic compounds
|
|
CA2584836A1
(en)
|
2004-10-15 |
2006-04-20 |
Neurosearch A/S |
Novel azabicyclic aryl derivatives and their medical use
|
|
US20070082350A1
(en)
|
2005-02-09 |
2007-04-12 |
Philip Landfield |
Assay and method for diagnosing and treating alzheimer's disease
|
|
DE102005038947A1
(de)
|
2005-05-18 |
2006-11-30 |
Grünenthal GmbH |
Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
|
|
US7897766B2
(en)
|
2005-09-23 |
2011-03-01 |
Abbott Laboratories |
Amino-aza-adamantane derivatives and methods of use
|
|
US8106066B2
(en)
|
2005-09-23 |
2012-01-31 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
|
|
GB0521508D0
(en)
|
2005-10-21 |
2005-11-30 |
Novartis Ag |
Organic compounds
|
|
US7371862B2
(en)
|
2005-11-11 |
2008-05-13 |
Pfizer Italia S.R.L. |
Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
PE20070823A1
(es)
|
2005-11-15 |
2007-08-09 |
Glaxo Group Ltd |
Sal tosilato de 8-(2,6-difluorofenil)-4-(4-fluoro-2-metilfenil)-2-{[2-hidroxi-1-(hidroximetil)etil]amino}pirido[2,3-]pirimidin-7(8h)-ona
|
|
US8541592B2
(en)
|
2005-11-22 |
2013-09-24 |
Amgen Inc. |
Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
|
|
TW200734338A
(en)
|
2006-01-16 |
2007-09-16 |
Organon Nv |
6-Phenyl-1H-imidazo [4,5-c] pyridine-4-carbonitrile derivatives
|
|
US7687515B2
(en)
|
2006-01-17 |
2010-03-30 |
N.V. Organon |
6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
|
|
NZ573735A
(en)
|
2006-05-19 |
2011-10-28 |
Abbott Lab |
Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives
|
|
MX2008016338A
(es)
|
2006-06-27 |
2009-01-16 |
Abbott Lab |
Derivados de pirrol y sus metodos de uso.
|
|
CA2659762A1
(en)
|
2006-06-27 |
2008-01-03 |
Abbott Laboratories |
Thiazoline and oxazoline derivatives and their methods of use
|
|
ITMI20061279A1
(it)
|
2006-06-30 |
2008-01-01 |
Consiglio Nazionale Ricerche |
Agonisti nicotinici selettivi per il sottotipo recettoriale alfa7,procedimento per la loro preparazione e relative composizioni farmaceutiche
|
|
US8314119B2
(en)
|
2006-11-06 |
2012-11-20 |
Abbvie Inc. |
Azaadamantane derivatives and methods of use
|
|
US8076350B2
(en)
|
2006-12-22 |
2011-12-13 |
Abbott Laboratories |
Spirocyclic azaadamantane derivatives and methods of use
|
|
CL2008000597A1
(es)
|
2007-03-01 |
2008-09-05 |
Glaxo Group Ltd |
Forma de dosificacion que comprende 6-(3-ciclobutil-2,3,4,5-tetrahidro-1h-benzo[d]azepin-7-il oxi)-n-metil nicotinamida, un estabilizante y un excipiente; procedimiento de preparacion; y su uso para tratar enfermedades neurologicas.
|
|
CL2008000596A1
(es)
|
2007-03-01 |
2008-09-05 |
Glaxo Group Ltd |
Forma de dosificacion que comprende 1-(6-[(3-ciclobutil-2,3,4,5-tetrahidro-1h-3-benzazepin-7-il)oxi]-3-piridinil)-2-pirrolidinona, un estabilizador, un excipiente; procedimiento de preparacion; y su uso para tratar enfermedades neurologicas.
|
|
EP2497771A1
(en)
|
2007-03-23 |
2012-09-12 |
Abbott Laboratories |
4 -substituted azaadamantane derivatives and methods of use thereof
|
|
MX2009010175A
(es)
|
2007-03-23 |
2009-10-12 |
Abbott Lab |
Derivados de acetamida y carboxamida de aza-adamantano y metodos de uso de los mismos.
|
|
EP2129672B1
(en)
|
2007-03-23 |
2011-05-18 |
Abbott Laboratories |
Azaadamantane ester and carbamate derivatives and methods of use thereof
|
|
EP2129673B1
(en)
|
2007-03-23 |
2013-11-06 |
AbbVie Inc. |
Amimomethyl azaadamantane derivatives and use thereof as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (nnrs)
|
|
WO2009017454A1
(en)
|
2007-07-30 |
2009-02-05 |
Astrazeneca Ab |
New therapeutic combination of a gsk3 inhibitor and an a7-nicotinic agonist 960
|
|
WO2009030716A1
(en)
|
2007-09-06 |
2009-03-12 |
Glaxo Group Limited |
Piperazine derivative having affinity for the histamine h3 receptor
|
|
WO2009047255A1
(en)
|
2007-10-09 |
2009-04-16 |
Ucb Pharma, S.A. |
Heterobicyclic compounds as histamine h4-receptor antagonists
|
|
US20090099099A1
(en)
|
2007-10-16 |
2009-04-16 |
Hong Wang |
Isoflavone Glycosides as Peroxisome Proliferator-Activated Receptor-alpha Modulator
|
|
GB0720444D0
(en)
|
2007-10-18 |
2007-11-28 |
Glaxo Group Ltd |
Novel compounds
|
|
MX2010005650A
(es)
|
2007-11-21 |
2010-06-02 |
Abbott Lab |
Derivados de diazabicicloalcano substituidos con biarilo.
|
|
CA2705296A1
(en)
|
2007-11-21 |
2009-05-28 |
Abbott Laboratories |
Biaryl substituted azabicyclic alkane derivatives as nicotinic acetylcholine receptor activity modulators
|
|
US8648085B2
(en)
|
2007-11-30 |
2014-02-11 |
Boehringer Ingelheim International Gmbh |
1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders
|
|
US8383657B2
(en)
|
2007-12-21 |
2013-02-26 |
Abbott Laboratories |
Thiazolylidine urea and amide derivatives and methods of use thereof
|
|
GB0800035D0
(en)
|
2008-01-02 |
2008-02-13 |
Glaxo Group Ltd |
Compounds
|
|
US8536221B2
(en)
|
2008-02-07 |
2013-09-17 |
Abbvie Inc. |
Amide derivatives as positive allosteric modulators and methods of use thereof
|
|
US7786171B2
(en)
|
2008-04-04 |
2010-08-31 |
Abbott Laboratories |
Amide derivatives as positive allosteric modulators and methods of use thereof
|
|
US8309577B2
(en)
|
2008-04-23 |
2012-11-13 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
|
|
WO2009137492A1
(en)
|
2008-05-05 |
2009-11-12 |
Abbott Laboratories |
Heteroaryl-fused macrocyclic pyrimidine derivatives
|
|
US20110189280A1
(en)
|
2008-08-29 |
2011-08-04 |
Allan James Clarke |
Dosage form comprising 1-isopropyl-4-hexahydro-1h-1,4-diazepine or a salt thereof
|
|
CN102209540A
(zh)
|
2008-11-11 |
2011-10-05 |
塔加西普特公司 |
使用α7-选择性配体的治疗方法
|
|
WO2010145208A1
(en)
|
2009-06-19 |
2010-12-23 |
Abbott Laboratories |
Diazahomoadamantane derivatives and methods of use thereof
|
|
GB0912778D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydro-oxazine derivatives
|
|
GB0912777D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydropyrimidone derivatives
|
|
TWI558398B
(zh)
|
2009-09-22 |
2016-11-21 |
諾華公司 |
菸鹼乙醯膽鹼受體α7活化劑之用途
|
|
ES2512727T3
(es)
|
2009-09-29 |
2014-10-24 |
Glaxo Group Limited |
Nuevos compuestos
|
|
CN102666540A
(zh)
|
2009-10-13 |
2012-09-12 |
Msd欧斯股份有限公司 |
用于治疗乙酰胆碱受体相关疾病的稠合吖嗪衍生物
|
|
US8507516B2
(en)
|
2009-10-28 |
2013-08-13 |
Bristol-Myers Squibb Company |
Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
|
US8278320B2
(en)
|
2009-10-28 |
2012-10-02 |
Bristol-Myers Squibb Company |
Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
|
TW201144303A
(en)
|
2010-02-17 |
2011-12-16 |
Janssen Pharmaceutica Nv |
Aminothiazolones as estrogen related receptor-α modulators
|
|
TWI510241B
(zh)
|
2010-02-18 |
2015-12-01 |
Vtv Therapeutice Llc |
苯基-雜芳基衍生物及其使用方法
|
|
GB201004179D0
(en)
|
2010-03-12 |
2010-04-28 |
Pulmagen Therapeutics Inflamma |
Enzyme inhibitors
|
|
CN103025744A
(zh)
|
2010-04-30 |
2013-04-03 |
百时美施贵宝公司 |
作为α-7烟碱乙酰胆碱受体配体前药的氮杂二环胺N-氧化物化合物
|
|
ES2524892T3
(es)
|
2010-09-02 |
2014-12-15 |
Glaxosmithkline Intellectual Property Development Limited |
2-(Benciloxi)benzamidas como inhibidores de LRRK2 quinasa
|
|
EP2619205B1
(en)
|
2010-09-23 |
2017-05-17 |
AbbVie Bahamas Ltd. |
Monohydrate of an azaadamantane derivative
|
|
FR2966827B1
(fr)
|
2010-10-27 |
2014-08-22 |
Kimonella Ventures Ltd |
Compose peptidique utile pour l'inhibition de la formation de plaques amyloides
|
|
EP2640378A4
(en)
|
2010-11-18 |
2014-05-21 |
Envivo Pharmaceuticals Inc |
INFLAMMATION TREATMENT WITH CERTAIN NICOTINIC ACID ALPHA-7 RECEPTOR AGONISTS IN COMBINATION WITH ACETYLCHOLINESTERASE INHIBITORS
|
|
EP2670744B1
(en)
|
2011-02-03 |
2015-05-27 |
Lupin Limited |
Pyrrole derivatives used as modulators of alpha7 nachr
|
|
JP2014076948A
(ja)
|
2011-02-09 |
2014-05-01 |
Astellas Pharma Inc |
イソキノリンアミド誘導体
|
|
AU2012221800B2
(en)
|
2011-02-23 |
2016-10-27 |
Lupin Limited |
Heteroaryl derivatives as alpha7 nAChR modulators
|
|
AU2012235779B2
(en)
|
2011-03-31 |
2017-03-02 |
Lupin Limited |
Pyrrole derivatives as nicotinic acetylcholine receptor modulators for use in the treatment of neurodegenerative disorders such as Alzheimer's and Parkinson's disease
|
|
ES2606043T3
(es)
|
2011-07-05 |
2017-03-17 |
Lupin Limited |
Derivados de biarilo como moduladores de nAChR
|
|
WO2013132380A1
(en)
|
2012-03-06 |
2013-09-12 |
Lupin Limited |
Thiazole derivatives as alpha 7 nachr modulators
|
|
CA2873984A1
(en)
|
2012-05-23 |
2013-11-28 |
Stemergie Biotechnology Sa |
Inhibitors of the activity of complex (iii) of the mitochondrial electron transport chain and use thereof
|
|
US9458179B2
(en)
|
2012-05-24 |
2016-10-04 |
Bristol-Myers Squibb Company |
Quinuclidine, 1-azabicyclo[2.2.1]heptane, 1-azabicyclo [3.2.1]octane, and 1-azabicyclo[3.2.2]nonane compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
|
JOP20130213B1
(ar)
|
2012-07-17 |
2021-08-17 |
Takeda Pharmaceuticals Co |
معارضات لمستقبلht3-5
|
|
WO2014072957A1
(en)
|
2012-11-12 |
2014-05-15 |
Lupin Limited |
Thiazole derivatives as alpha 7 nachr modulators
|
|
WO2014083003A1
(en)
|
2012-11-27 |
2014-06-05 |
Shire International Gmbh |
Pro-cognitive compound
|
|
BR112015013771B1
(pt)
|
2012-12-11 |
2022-10-04 |
Novartis Ag |
Composição que compreende um ativador do receptor alfa 7, nicotínico de acetilcolina (nachr) como biomarcador preditivo de resposta ao tratamento de ativador do dito receptor
|
|
US9617211B2
(en)
|
2013-01-16 |
2017-04-11 |
Lupin Limited |
Pyrrole derivatives as alpha 7 nAChR modulators
|
|
TR201904614T4
(en)
|
2013-02-27 |
2019-05-21 |
Mochida Pharm Co Ltd |
Novel pyrazole derivative.
|
|
US9617210B2
(en)
|
2013-03-13 |
2017-04-11 |
Lupin Limited |
Pyrrole derivatives as alpha 7 NACHR modulators
|
|
TW201446243A
(zh)
|
2013-06-03 |
2014-12-16 |
Lupin Ltd |
4-(5-(4-氯苯基)-2-(2-環丙基乙醯基)-1,4-二甲基-1氫-吡咯-3-基)苯磺醯胺作為α7尼古丁乙醯膽鹼受體調節劑
|
|
WO2014203150A1
(en)
|
2013-06-17 |
2014-12-24 |
Lupin Limited |
Pyrrole derivatives as alpha 7 nachr modulators
|
|
WO2015066371A1
(en)
|
2013-10-31 |
2015-05-07 |
Forum Pharmaceuticals, Inc. |
SPIRO-OXADIAZOLINE COMPOUNDS AS AGONISTS OF α-7-NICOTINIC ACETYLCHOLINE RECEPTORS
|
|
CA2971413A1
(en)
|
2014-12-16 |
2016-06-23 |
Axovant Sciences Gmbh |
Geminal substituted quinuclidine amide compounds as agonists of alpha-7 nicotinic acetylcholine receptors
|